Developing a voice biomarker for emotional/ behavioral disorders in an emerging science.
Our multidisciplinary team of experts with backgrounds in academia, mental health research, and technology collaborators such as Google, are helping revolutionize the approach to mental healthcare in youth.
Dr. Yared Alemu
Founder and CEO
Dr. Alemu has over 20 years of experience as a psychologist, clinical supervisor, researcher, and administrator. He is an expert in digital mental healthcare and using technology to support precision and individualized treatment approaches to mental health treatment. TQI’s voice biomarker product, Clarity AI, provides objective insights into the impact of trauma on the human brain. Most importantly, the technology Dr. Alemu’s team develops translates these objective insights into clinical application to support therapists in a problematic clinical setting to improve the quality of young lives.
These brain-based insights are essential for the system of care that provides mental health services for 5-Million children and adolescents from low-income families; despite an investment of 250 billion annually, there is limited evidence that it has made a tangible difference in the lives of youth from low-income communities. TQI’s digital mental health solutions address the stubborn disparities in mental health treatment outcomes. We are working with providers, payers, policymakers, and families to improve the quality of life for young people collaboratively.
Desmond Caulley is a machine learning Ph.D. candidate at the Georgia Institute of Technology specializing in the area of speaker identification and speech recognition. His current research involves the automatic analysis of audio recordings from children with autism spectrum disorder to measure language progression and treatment effectiveness. He received a bachelor’s degree in electrical and Computer Engineering from Cornell University. His research background includes work at the MIT Lincoln Lab.
Sedara Burson, LPC, MAC, CPCS
Director of Technology Implementation and Customer Engagement
Sedara, is responsible for designing and implementing programs to improve therapist participation and ensure maximum engagement by clients and customers. Sedara has worked in Corporate America, the nonprofit sector, community mental health clinics, hospital settings and academia. Her passion is to serve others through training, education, and supervision. She has 13 years of clinical experience and 6 years of Behavioral Health Management experience. She is also an author of children’s books. Her latest book was featured at The King Center’s Students with King Reading Corner.
Marketing, Branding, and Research Associate
Allison is an undergraduate student at Georgia Institute of Technology studying Computer Science and joined TQIntelligence in August 2021. At TQIntelligence, she helps with research, digital marketing, and web design for TQIntelligence.
The Scientific Advisory / Voice Analytics Team
Dr. Pegah Moghaddam
A clinical psychologist who specializes in the assessment and treatment of eating disorders, trauma, mood and anxiety disorders. She typically works with older adolescents, young adults, and adults.
Dr. Michelle K. Lyn
A licensed psychologist with over 20 years of experience working in a variety of clinical settings including Private Practice, Collegiate Mental Health, and Veterans’ Affairs. She provides consultation services and specializes in cultural diversity, identity development, women’s issues, and grief and loss.
Dr. Ashutosh Sabharwal, Lead Scientific Advisor
A Professor and Chair of the Department of Electrical and Computer Engineering at Rice University. One area of his research is healthcare technologies. He is currently leading several NSF-funded center-scale projects and is the Fellow of the IEEE and the National Academy of Inventors.
Dr. Shreece Fields
David D. Anderson
Dr. Rosa Arriaga
The Advisory Board
Anthony Wilkins, CFA
Mark has devoted decades to focus on making lives better for children, youth, and their families, and has experience with Software-as-a-Service startups and venture capital-backed companies to accelerate the growth of healthcare and social service technologies. Mark has also been appointed to lead state government agencies, where he worked with family and child services and oversaw thousands of staff and contracted providers.
Senior Director of Oncology R&D Business Development
Dominic McDonald is a Senior Director of Oncology R&D Business Development at AstraZeneca. Throughout his career, Dominic has been a strategic leader & thought partner. While at Genentech / Roche, he served as an internal consultant to drug development teams supporting decision making from preclinical through phase 3, ensuring that oncology therapeutics developed would be viable globally. At AstraZeneca, he initially was a part of the global commercial launch team of a leukemia therapeutic. Currently, Dominic sits on the Search & Evaluation team identifying external innovation to support the AstraZeneca oncology portfolio. Dominic holds a BS in Chemical-Biological Engineering from MIT and a MBA from the MIT Sloan School of Management. He resides in Rockville, Maryland, just outside of Washington, DC.